Excellent effectiveness of direct-acting antivirals for HCV treatment in patients with cirrhosis: Analysis of 3345 patients from the Lombardia Network
Elisabetta Degasperi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), S. Fagiuoli(Ospedale Papa Giovanni XXIII), Roberto Gulminetti(University of Pavia), Tiziana Quirino(Ospedale di Circolo di Busto Arsizio), Paolo Sacchi, S. Zaltron(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Alessio Aghemo, L. Pasulo(Ospedale Papa Giovanni XXIII), Silvia Fargion(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Massimo Zuin(AOL (United States)), Agostino Colli(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Franco Maggiolo(Ospedale Papa Giovanni XXIII), A. Corbellini(ASST Melegnano e della Martesana), Maria Grazia Rumi(University of Milan), Angelo Pan(Istituti Ospitalieri di Cremona), Pietro Lampertico(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Giuliano Rizzardini, Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Angelo Rossini(Centro Universitário Barão de Mauá), Paolo Grossi(University of Insubria)
Cited by 0
Related Papers
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2010|725
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539